DocGo (DCGO) Stock: Buy, Sell, or Hold?
$0.23
+0.01 (+2.53%)
▲
5d:
-11.32%
30d:
-24.25%
90d:
-64.62%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (80%)
Quality Score
45/100
Position
OVERSOLD
30-Day Fair Range
$0.24 – $0.32
Position: OVERSOLD
Forward P/E & Valuation
0.7x
CHEAP
vs 2.4x historical avg
Wall Street Target
$1.88
+731.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.21 / $0.28
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: DCGO is down 11.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When DCGO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.08
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$0.67
65.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DCGO is currently trading at $0.23, which is considered oversold relative to its 30-day fair value range of $0.24 to $0.32. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.7) compared to its historical average (2.4). Remarkably, the market is currently pricing in an annual earnings decline of 33.4% over the next few years. This pessimistic expectation contrasts with the company's recent 9.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, DCGO is in a strong downtrend. Immediate support is located at $0.21, while resistance sits at $0.28.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.88 (+731.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DCGO is in a strong downtrend. Immediate support is located at $0.21, while resistance sits at $0.28.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.88 (+731.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.24 -
$0.32
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Trading Range & Key Levels
30-Day Trading Range
$0.24 -
$0.32
Current vs Trading Range
OVERSOLD
Support Level
$0.21
Resistance Level
$0.28
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 731.9% below Wall St target ($1.88)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
0.70
Wall Street Target
$1.88
(+731.9%)
Revenue Growth (YoY)
-8.7%
Earnings Growth (YoY)
9.0%
Profit Margin
-65.3%
Valuation Discount vs History
-33.4% cheaper
PE vs Historical
0.7 vs 2.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-33.4%
(market-implied from PE analysis)
1-Year Target
$0.20
(-10%)
2-Year Target
$0.18
(-19%)
3-Year Target
$0.16
(-27%)
3-Yr Target (if PE normalizes)
(PE: 1→2)
$0.56
(+150%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.7 to 2.4
Stabilization Target:
$0.77
(+242.9%)
PE Expansion Potential:
+242.9%
Share DCGO Analysis
Share this live DCGO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (DCGO)
Bullish
3 Retail Mentions
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
DocGo reported progress in transitioning to a vertically integrated hybrid care provider and narrowed losses, but a revised revenue outlook and CEO exit raised concerns.
Key Retail Themes:
Transition to vertically integrated hybrid care provider
Prioritizing profitability over revenue growth
CEO exit
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 2:17 PM ET
Data refreshes hourly during market hours. Next update: 3:17 PM
Data refreshes hourly during market hours. Next update: 3:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DCGO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$306 | 50 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 34 SELL |
|
CON
Concentra Group Holdings… |
STRONG BUY
11 analysts |
$44 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$156 | 36 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive DCGO Research Pages
